Regulation of Pro-Inflammatory Macrophage Polarization via Lipid Nanoparticles Mediated Delivery of Anti-Prostaglandin-E2 siRNA
Abstract
:1. Introduction
2. Materials and Methods
2.1. Chemicals and Reagents
2.2. Synthesis of Nanoparticles
2.3. Characterization of LNPs
2.4. Cell Culture and Maintenance
2.5. Biocompatibility of the LNPs
2.6. Binding Efficiency of siRNA with LNPs through Gel Retardation Assay
2.7. RNA Extraction and Real-Time Quantitative PCR
2.8. Protein Extraction and Western Blot
2.9. Statistical Analysis
3. Results
3.1. Synthesis and Characterization of LNPs
3.2. Biocompatibility of the LNP
3.3. Binding Efficiency of siRNA with Lipid Nanoparticle (LNPs)
3.4. Detection of Gene-Silencing through qRT-PCR
3.5. Western Blot
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Orecchioni, M.; Ghosheh, Y.; Pramod, A.B.; Ley, K. Macrophage polarization: Different gene signatures in M1(Lps+) vs. Classically and M2(LPS-) vs. Alternatively activated macrophages. Front. Immunol. 2019, 10, 1–14. [Google Scholar] [CrossRef] [PubMed]
- Ahmad, S.; Zaki, A.; Manda, K.; Mohan, A.; Syed, M.A. Vitamin-D ameliorates sepsis-induced acute lung injury via augmenting miR-149-5p and downregulating ER stress. J. Nutr. Biochem. 2022, 110, 109130. [Google Scholar] [CrossRef] [PubMed]
- Chen, X.; Tang, J.; Shuai, W.; Meng, J.; Feng, J.; Han, Z. Macrophage polarization and its role in the pathogenesis of acute lung injury/acute respiratory distress syndrome. Inflamm. Res. 2020, 69, 883–895. [Google Scholar] [CrossRef] [PubMed]
- Slauch, J.M. How does the oxidative burst of macrophages kill bacteria? Still an open question. Mol. Microbiol. 2011, 80, 580–583. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Das, A.; Sinha, M.; Datta, S.; Abas, M.; Chaffee, S.; Sen, C.K.; Roy, S. Monocyte and macrophage plasticity in tissue repair and regeneration. Am. J. Pathol. 2015, 185, 2596–2606. [Google Scholar] [CrossRef] [Green Version]
- Patel, U.; Rajasingh, S.; Samanta, S.; Cao, T.; Dawn, B.; Rajasingh, J. Macrophage polarization in response to epigenetic modifiers during infection and inflammation. Drug Discov. Today 2017, 22, 186–193. [Google Scholar] [CrossRef] [Green Version]
- Zaki, A.; Ali, M.S.; Hadda, V.; Ali, S.M.; Chopra, A.; Fatma, T. Long non-coding RNA (lncRNA): A potential therapeutic target in acute lung injury. Genes Dis. 2021, 9, 1258–1268. [Google Scholar] [CrossRef]
- Anderson, J.M.; Rodriguez, A.; Chang, D.T. Foreign body reaction to biomaterials. Semin. Immunol. 2008, 20, 86–100. [Google Scholar] [CrossRef] [Green Version]
- Williams, J.A.; Shacter, E. Regulation of Macrophage Cytokine Production by Prostaglandin E2. J. Biol. Chem. 1997, 272, 25693–25699. [Google Scholar] [CrossRef] [Green Version]
- Ricciotti, E.; FitzGerald, G.A. Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 986–1000. [Google Scholar] [CrossRef]
- Kim, Y.-G.; Udayanga, K.G.S.; Totsuka, N.; Weinberg, J.B.; Núñez, G.; Shibuya, A. Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE₂. Cell Host Microbe 2014, 15, 95–102. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Eliopoulos, A.G. Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. EMBO J. 2002, 21, 4831–4840. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Carthew, R.W.; Sontheimer, E.J. Origins and Mechanisms of miRNAs and siRNAs. Cell 2009, 136, 642–655. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Morris, K.V. siRNA-mediated transcriptional gene silencing: The potential mechanism and a possible role in the histone code. Cell. Mol. Life Sci. 2005, 62, 3057–3066. [Google Scholar] [CrossRef] [PubMed]
- Choung, S.; Kim, Y.J.; Kim, S.; Park, H.-O.; Choi, Y.-C. Chemical modification of siRNAs to improve serum stability without loss of efficacy. Biochem. Biophys. Res. Commun. 2006, 342, 919–927. [Google Scholar] [CrossRef]
- Leung, A.K.K.; Tam, Y.Y.C.; Cullis, P.R. Lipid nanoparticles for short interfering RNA delivery. Adv. Genet. 2014, 88, 71–110. [Google Scholar] [CrossRef]
- Huang, Y.; Hong, J.; Zheng, S.; Ding, Y.; Guo, S.; Zhang, H.; Zhang, X.; Du, Q.; Liang, Z. Elimination pathways of systemically delivered siRNA. Mol. Ther. 2011, 19, 381–385. [Google Scholar] [CrossRef]
- Beloqui, A.; Solinís, M.Á.; Rodríguez-Gascón, A.; Almeida, A.J.; Préat, V. Nanostructured lipid carriers: Promising drug delivery systems for future clinics. Nanomed. Nanotechnol. Biol. Med. 2016, 12, 143–161. [Google Scholar] [CrossRef]
- Dong, Y.; Siegwart, D.J.; Anderson, D.G. Strategies, design, and chemistry in siRNA delivery systems. Adv. Drug Deliv. Rev. 2019, 144, 133–147. [Google Scholar] [CrossRef]
- Dai, C.C.; Huang, W.; Yang, J.; Hussein, W.M.; Wang, J.; Khalil, Z.G.; Capon, R.J.; Toth, I.; Stephenson, R.J. Polyethylenimine quantity and molecular weight influence its adjuvanting properties in liposomal peptide vaccines. Bioorg. Med. Chem. Lett. 2021, 40, 127920. [Google Scholar] [CrossRef]
- Zaki, A.; Aziz, M.N.; Ahmad, R.; Ahamad, I.; Ali, M.S.; Yasin, D.; Afzal, B.; Ali, S.M.; Chopra, A.; Hadda, V.; et al. Synthesis, purification and characterization of Plectonema derived AgNPs with elucidation of the role of protein in nanoparticle stabilization. RSC Adv. 2022, 12, 2497–2510. [Google Scholar] [CrossRef]
- Yasin, D.; Zafaryab, M.; Ansari, S.; Ahmad, N.; Khan, N.F.; Zaki, A.; Alam Rizvi, M.M.; Fatma, T. Evaluation of antioxidant and anti-proliferative efficacy of Nostoc muscorum NCCU-442. Biocatal. Agric. Biotechnol. 2019, 17, 284–293. [Google Scholar] [CrossRef]
- Sauler, M.; Bazan, I.S.; Lee, P.J. Cell Death in the Lung: The Apoptosis-Necroptosis Axis. Annu. Rev. Physiol. 2019, 81, 375–402. [Google Scholar] [CrossRef] [PubMed]
- Bhattacharjee, S. DLS and zeta potential—What they are and what they are not? J. Control. Release 2016, 235, 337–351. [Google Scholar] [CrossRef] [PubMed]
- Kaszuba, M.; Connah, M.T.; McNeil-Watson, F.K.; Nobbmann, U. Resolving Concentrated Particle Size Mixtures Using Dynamic Light Scattering. Part. Part. Syst. Charact. 2007, 24, 159–162. [Google Scholar] [CrossRef]
- Zhao, X.; Zhu, S.; Song, Y.; Zhang, J.; Yang, B. Thermal responsive fluorescent nanocomposites based on carbon dots. RSC Adv. 2015, 5, 15187–15193. [Google Scholar] [CrossRef]
- Kim, K.-H.; Xing, H.; Zuo, J.-M.; Zhang, P.; Wang, H. TEM based high resolution and low-dose scanning electron nanodiffraction technique for nanostructure imaging and analysis. Micron 2015, 71, 39–45. [Google Scholar] [CrossRef] [Green Version]
- Cumberland, S.A.; Lead, J.R. Particle size distributions of silver nanoparticles at environmentally relevant conditions. J. Chromatogr. A 2009, 1216, 9099–9105. [Google Scholar] [CrossRef]
- Hoshyar, N.; Gray, S.; Han, H.; Bao, G. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine 2016, 11, 673–692. [Google Scholar] [CrossRef] [Green Version]
- Xu, L.; Wang, X.; Liu, Y.; Yang, G.; Falconer, R.J.; Zhao, C.-X. Lipid Nanoparticles for Drug Delivery. Adv. NanoBiomed Res. 2022, 2, 2100109. [Google Scholar] [CrossRef]
- Raval, N.; Maheshwari, R.; Kalyane, D.; Youngren-Ortiz, S.R.; Chougule, M.B.; Tekade, R.K. Importance of Physicochemical Characterization of Nanoparticles in Pharmaceutical Product Development. In Basic Fundamentals of Drug Delivery; Elsevier: Amsterdam, The Netherlands, 2019; pp. 369–400. [Google Scholar]
- Tsuge, K.; Inazumi, T.; Shimamoto, A.; Sugimoto, Y. Molecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases. Int. Immunol. 2019, 31, 597–606. [Google Scholar] [CrossRef] [PubMed]
- Hohjoh, H.; Inazumi, T.; Tsuchiya, S.; Sugimoto, Y. Prostanoid receptors and acute inflammation in skin. Biochimie 2014, 107, 78–81. [Google Scholar] [CrossRef] [PubMed]
- Hart, F.D.; Huskisson, E.C. Non-steroidal anti-inflammatory drugs. Current status and rational therapeutic use. Drugs 1984, 27, 232–255. [Google Scholar] [CrossRef] [PubMed]
- Wynn, T.A.; Vannella, K.M. Macrophages in Tissue Repair, Regeneration, and Fibrosis. Immunity 2016, 44, 450–462. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mosser, D.M.; Hamidzadeh, K.; Goncalves, R. Macrophages and the maintenance of homeostasis. Cell. Mol. Immunol. 2021, 18, 579–587. [Google Scholar] [CrossRef]
- Xue, Q.; Yan, Y.; Zhang, R.; Xiong, H. Regulation of iNOS on Immune Cells and Its Role in Diseases. Int. J. Mol. Sci. 2018, 19, 3805. [Google Scholar] [CrossRef] [Green Version]
- Xiong, H.; Zhu, C.; Li, F.; Hegazi, R.; He, K.; Babyatsky, M.; Bauer, A.J.; Plevy, S.E. Inhibition of interleukin-12 p40 transcription and NF-kappaB activation by nitric oxide in murine macrophages and dendritic cells. J. Biol. Chem. 2004, 279, 10776–10783. [Google Scholar] [CrossRef] [Green Version]
- Giordano, D.; Li, C.; Suthar, M.S.; Draves, K.E.; Ma, D.Y.; Gale, M.; Clark, E.A. Nitric oxide controls an inflammatory-like Ly6C hi PDCA1 + DC subset that regulates Th1 immune responses. J. Leukoc. Biol. 2011, 89, 443–455. [Google Scholar] [CrossRef] [Green Version]
- Dinarello, C.A. Biologic basis for interleukin-1 in disease. Blood 1996, 87, 2095–2147. [Google Scholar] [CrossRef] [Green Version]
- Scotton, C.J.; Martinez, F.O.; Smelt, M.J.; Sironi, M.; Locati, M.; Mantovani, A.; Sozzani, S. Transcriptional profiling reveals complex regulation of the monocyte IL-1 beta system by IL-13. J. Immunol. 2005, 174, 834–845. [Google Scholar] [CrossRef]
- Martinez, F.O.; Gordon, S.; Locati, M.; Mantovani, A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: New molecules and patterns of gene expression. J. Immunol. 2006, 177, 7303–7311. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zasłona, Z.; Pålsson-McDermott, E.M.; Menon, D.; Haneklaus, M.; Flis, E.; Prendeville, H.; Corcoran, S.E.; Peters-Golden, M.; O’Neill, L.A.J. The Induction of Pro–IL-1β by Lipopolysaccharide Requires Endogenous Prostaglandin E2 Production. J. Immunol. 2017, 198, 3558–3564. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Almatroudi, A.; Alsahli, M.A.; Syed, M.A.; Khan, A.A.; Rahmani, A.H. Regulation of Pro-Inflammatory Macrophage Polarization via Lipid Nanoparticles Mediated Delivery of Anti-Prostaglandin-E2 siRNA. Curr. Issues Mol. Biol. 2023, 45, 1-11. https://doi.org/10.3390/cimb45010001
Almatroudi A, Alsahli MA, Syed MA, Khan AA, Rahmani AH. Regulation of Pro-Inflammatory Macrophage Polarization via Lipid Nanoparticles Mediated Delivery of Anti-Prostaglandin-E2 siRNA. Current Issues in Molecular Biology. 2023; 45(1):1-11. https://doi.org/10.3390/cimb45010001
Chicago/Turabian StyleAlmatroudi, Ahmad, Mohammed A. Alsahli, Mansoor Ali Syed, Amjad Ali Khan, and Arshad Husain Rahmani. 2023. "Regulation of Pro-Inflammatory Macrophage Polarization via Lipid Nanoparticles Mediated Delivery of Anti-Prostaglandin-E2 siRNA" Current Issues in Molecular Biology 45, no. 1: 1-11. https://doi.org/10.3390/cimb45010001